These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 29505580)

  • 41. Proof-of-principle of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: final results of a study in Mali and Senegal.
    Traore MO; Sarr MD; Badji A; Bissan Y; Diawara L; Doumbia K; Goita SF; Konate L; Mounkoro K; Seck AF; Toe L; Toure S; Remme JH
    PLoS Negl Trop Dis; 2012; 6(9):e1825. PubMed ID: 23029586
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of long-term treatment of onchocerciasis with ivermectin in Kaduna State, Nigeria: first evidence of the potential for elimination in the operational area of the African Programme for Onchocerciasis Control.
    Tekle AH; Elhassan E; Isiyaku S; Amazigo UV; Bush S; Noma M; Cousens S; Abiose A; Remme JH
    Parasit Vectors; 2012 Feb; 5():28. PubMed ID: 22313631
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A community-based cross-sectional study of the epidemiology of onchocerciasis in unmapped villages for community directed treatment with ivermectin in Jimma Zone, southwestern Ethiopia.
    Dana D; Debalke S; Mekonnen Z; Kassahun W; Suleman S; Getahun K; Yewhalaw D
    BMC Public Health; 2015 Jul; 15():595. PubMed ID: 26130117
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Risk factors for epilepsy in Bas-Uélé Province, Democratic Republic of the Congo: a case-control study.
    Colebunders R; Mandro M; Mokili JL; Mucinya G; Mambandu G; Pfarr K; Reiter-Owona I; Hoerauf A; Tepage F; Levick B; Begon M; Laudisoit A
    Int J Infect Dis; 2016 Aug; 49():1-8. PubMed ID: 27210267
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Onchocerciasis Elimination Program for the Americas (OEPA).
    Sauerbrey M
    Ann Trop Med Parasitol; 2008 Sep; 102 Suppl 1():25-9. PubMed ID: 18718151
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interruption of transmission of Onchocerca volvulus in the Southern Chiapas Focus, México.
    Rodríguez-Pérez MA; Domínguez-Vázquez A; Unnasch TR; Hassan HK; Arredondo-Jiménez JI; Orozco-Algarra ME; Rodríguez-Morales KB; Rodríguez-Luna IC; Prado-Velasco FG
    PLoS Negl Trop Dis; 2013; 7(3):e2133. PubMed ID: 23556018
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Knowledge, attitude and practice of community drug distributors' about onchocerciasis and community directed treatment with ivermectin in Quara district, North Western Ethiopia.
    Weldegebreal F; Medhin G; Weldegebriel Z; Legesse M
    BMC Res Notes; 2016 Apr; 9():206. PubMed ID: 27053243
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Progress towards elimination of onchocerciasis transmission in Mali: A "pre-stop MDA" survey in 18 transmission zones.
    Dolo H; Coulibaly ME; Sow M; Coulibaly YI; Doumbia M; Sangare M; Sanogo A; Dembele B; Guindo B; Coulibaly M; Keita M; Soumaoro L; Diarra D; Dicko B; Hamill L; Doumbia S; Sangho H; Sangare Y; Zhang Y; Tallant J; Yaro AS; Mackenzie C; Nutman TB; Boakye D
    PLoS Negl Trop Dis; 2023 Nov; 17(11):e0011632. PubMed ID: 37967137
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Persistence of onchocerciasis and associated dermatologic and ophthalmic pathologies after 27 years of ivermectin mass drug administration in the middle belt of Ghana.
    Otabil KB; Basáñez MG; Ankrah B; Opoku SA; Kyei DO; Hagan R; Ababio R; Bart-Plange EJ; Babae TN; Kudzordzi PC; Darko VA; Bamfo JG; Ameyaw J; Raji AS; Hadermann A; Schallig HDFH; Colebunders R
    Trop Med Int Health; 2023 Nov; 28(11):844-854. PubMed ID: 37846505
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of serological and parasitological assessments of Onchocerca volvulus transmission after 7 years of mass ivermectin treatment in Mexico.
    Rodríguez-Pérez MA; Danis-Lozano R; Rodríguez MH; Bradley JE
    Trop Med Int Health; 1999 Feb; 4(2):98-104. PubMed ID: 10206263
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of repeated treatments with ivermectin on the incidence of onchocerciasis in northern Cameroon.
    Boussinesq M; Chippaux JP; Ernould JC; Quillevere D; Prod'hon J
    Am J Trop Med Hyg; 1995 Jul; 53(1):63-7. PubMed ID: 7625535
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Interruption of Onchocerca volvulus transmission in the Abu Hamed focus, Sudan.
    Higazi TB; Zarroug IM; Mohamed HA; Elmubark WA; Deran TC; Aziz N; Katabarwa M; Hassan HK; Unnasch TR; Mackenzie CD; Richards F; Hashim K
    Am J Trop Med Hyg; 2013 Jul; 89(1):51-7. PubMed ID: 23690554
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impact of combined large-scale ivermectin distribution and vector control on transmission of Onchocerca volvulus in the Niger basin, Guinea.
    Guillet P; Sékétéli A; Alley ES; Agoua H; Boatin BA; Bissan Y; Akpoboua LK; Quillévéré D; Samba EM
    Bull World Health Organ; 1995; 73(2):199-205. PubMed ID: 7743591
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of semiannual treatments of ivermectin on the prevalence and intensity of Onchocerca volvulus skin infection, ocular lesions, and infectivity of Simulium ochraceum populations in southern Mexico.
    Rodriguez-Perez MA; Rodriguez MH; Margeli-Perez HM; Rivas-Alcala AR
    Am J Trop Med Hyg; 1995 May; 52(5):429-34. PubMed ID: 7771609
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Community-directed vector control to supplement mass drug distribution for onchocerciasis elimination in the Madi mid-North focus of Northern Uganda.
    Jacob BG; Loum D; Lakwo TL; Katholi CR; Habomugisha P; Byamukama E; Tukahebwa E; Cupp EW; Unnasch TR
    PLoS Negl Trop Dis; 2018 Aug; 12(8):e0006702. PubMed ID: 30148838
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Onchocerciasis transmission in Ghana: persistence under different control strategies and the role of the simuliid vectors.
    Lamberton PH; Cheke RA; Winskill P; Tirados I; Walker M; Osei-Atweneboana MY; Biritwum NK; Tetteh-Kumah A; Boakye DA; Wilson MD; Post RJ; Basañez MG
    PLoS Negl Trop Dis; 2015 Apr; 9(4):e0003688. PubMed ID: 25897492
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prevalence of epilepsy in the onchocerciasis endemic middle belt of Ghana after 27 years of mass drug administration with ivermectin.
    Otabil KB; Ankrah B; Bart-Plange EJ; Donkoh ES; Avarikame FA; Ofori-Appiah FO; Babae TN; Kudzordzi PC; Darko VA; Ameyaw J; Bamfo JG; Sakibu RA; Antwi-Berko D; Fodjo JNS; Basáñez MG; Schallig HDFH; Colebunders R
    Infect Dis Poverty; 2023 Aug; 12(1):75. PubMed ID: 37587500
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact of ivermectin and vector control on onchocerciasis transmission in Togo: Assessing the empirical evidence on trends in infection and entomological indicators.
    Vinkeles Melchers NVS; Agoro S; Togbey K; Padjoudoum K; Telou IG; Karabou P; Djatho T; Datagni M; Dorkenoo AM; Kassankogno Y; Bronzan R; Stolk WA
    PLoS Negl Trop Dis; 2024 Jul; 18(7):e0012312. PubMed ID: 39038058
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Seventeen years of annual distribution of ivermectin has not interrupted onchocerciasis transmission in North Region, Cameroon.
    Katabarwa MN; Eyamba A; Nwane P; Enyong P; Yaya S; Baldiagaï J; Madi TK; Yougouda A; Andze GO; Richards FO
    Am J Trop Med Hyg; 2011 Dec; 85(6):1041-9. PubMed ID: 22144441
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A Serological Survey of Human Onchocerciasis in Yemen.
    Mackenzie CD; Al-Kubati AS; Al-Qubati Y; Behan-Braman A; Kubofcik J; Hopkins A; Nutman TB
    Am J Trop Med Hyg; 2018 Oct; 99(4):1049-1052. PubMed ID: 30084341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.